Target Population

Patients with Coronary Artery Disease & Ischemic Heart Disease: For those with myocardial infarction or severe chest discomfort, we provide emergency cardiac interventional therapies.

Description

We provide high-quality services to heart disease patients in southern Taiwan. Our experienced team continuously learns and innovates, using the best and latest interventional cardiovascular treatment technologies to provide comprehensive and immediate services to patients.

Key Highlights

Pioneering the nation's first 24/7 non-stop emergency intervention service, protecting heart attack patients around the clock in Taiwan.

Service Data

Annual cardiac catheterization volume reaches 1,800–2,000 cases, with acute heart attacks making up about 9% (around 150–200 procedures).

Featured Outcomes

The time to perform the first electrocardiogram (ECG) is under 10 minutes, with a target achievement rate of 90% or higher.
The proportion of STEMI patients eligible for and administered antiplatelet therapy—such as Aspirin (ASA) combined with Clopidogrel, Ticagrelor, or Prasugrel—in the emergency department reaches a target achievement rate of 95% or higher.
For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (Primary PCI), the door-to-wire time is under 90 minutes, with a target achievement rate of 90% or higher.
For patients transferred from an affiliate hospital or branch within the same healthcare system, the door-to-wire time is under 60 minutes, with a target achievement rate of 90% or higher.

Safety Outcomes

Regular intra-departmental or multidisciplinary team meetings on medical quality and patient safety are held monthly, reviewing cases that include:
A. Mortality Cases: Unexpected deaths or deaths outside the natural course of the disease.
B. Complication Cases: Unexpected complications caused by examinations or procedures, or severe surgical complications (defined as Grade III or higher according to the Annals of Surgery classification, requiring surgical intervention, being life-threatening, or leading to organ failure).
C. Cases Deemed Necessary for Multidisciplinary Review by the Department Chief, Division Head, or Meeting Chair: Such as unplanned returns to the operating room, unplanned readmissions within 14 days for the same or related conditions, emergency department (ED) returns within 72 hours with subsequent admission, ED returns within 3 days of discharge, prolonged hospital stays (length of stay > 30 days, ICU stay > 14 days, or high-cost ultra-long hospitalizations), and post-resuscitation cases.

AMI-Related Indicators:

Door-to-balloon (D2B) time < 90 minutes (Target rate > 90%)
Inter-hospital transfer D2B time < 60 minutes (Target rate > 90%)
AMI mortality rate: < 13.4%
Average Cardiac Catheterization Complication Rate: < 1%

Satisfaction

Quality Improvement: Patient Satisfaction Survey
Mechanism: Patients or caregivers scan a QR code to complete an anonymous cloud-based survey to evaluate coronary artery disease care.
Results: Statistical analysis demonstrates an average satisfaction rate exceeding 80%.
Action Plan: Substandard items (falling below benchmarks) are formally reviewed in multidisciplinary team meetings to devise corrective and preventive actions.

International Achievements

Asia's First: The first hospital in Asia to implement transradial cardiac catheterization and intervention.
High Volume & Expertise: Over 108,975 cardiac catheterization procedures completed as of May 2026, with a transradial success/utilization rate of > 95%.
Global Impact: Since 2005, we have trained 36 international physicians from Egypt, China, Singapore, Libya, Iraq, Pakistan, and beyond.

Benefits and Impacts

2006: Awarded the Silver Medal for Acute Myocardial Infarction Care; recognized as the first hospital in Asia to perform cardiac catheterization and interventional therapy via the transradial approach.
2019: Achieved "Heart Failure" Disease-Specific Care Certification from the Joint Commission of Taiwan (JCT).
2021: Awarded the Symbol of National Quality (SNQ) for "Restarting from the Heart, Rhythm for Life: A 3-Step Preoperative Disinfection Protocol to Prevent Pacemaker Infections."
2022: Achieved "Coronary Artery Disease" Quality of Care Certification from the Joint Commission of Taiwan (JCT).
2023: Awarded the Symbol of National Quality (SNQ) for "Precision Anesthesia-Assisted Catheter Ablation.
2025: The Division of Cardiology won the "Excellent Team Award" in the System Category at the National Healthcare Quality Awards (NHQA), and the "Outstanding Team Award" in the Shared Decision Making (SDM) Clinical Application Category from the Joint Commission of Taiwan (JCT)